. 2. 2. 6 . 6 6 © © © © © © © 0 © ew © © we © we © tw ew ow lw we tlt lw eh tll tl tl ... 2 2 2 + 6 6 © «© «© © © © © © © © we © we © ew we tw we we we ow ee we we tht ... 2. 2 « © © © © © © we ee 2. Residual Radiation . . 1. Data Evaluation .....-. 1 «© 1 «© 0 © ee © © ew © we © we we ow +. 6 «© © «© © «© © © ee ee oe © we we ew we oe we we et te ACKNOWLEDGMENTS INTRODUCTION . 2. IV. E. GENERAL MEDICAL SURVEYS .... we we ee te ew ew we we we we we ww ee © © @ © ww A. Background . 2. 2 2 1 we ee ww we we we he Methods . . 2. «© 1. Procedures . «© 2. © 2. © 2 e 6 © © © «6 © C. Results « 6 © «© «© © © © © © ow ew ew ww ht we wl .. . 2. 6 «© © «© © © © © © we wh we Methods .. 2. 6 «© «© e «© Results and Discussion . © . © 1. © 2. © 6 ee ss we eh eo ee we tt htt we ew we we wh ww 2. 2. © «© «© © © © © © ww © © we © © © © «es eo we . we ew we we . eo ew ew we ow ew te we we we we tt wt Pe 2. Control Populations . . 2. 6 HEMATOLOGIC OBSERVATIONS A. B. C. B. C. eh eh we ht tht tw tt tlt ........ 6 © «© © we we be wo © © Background . . 6 6 6 6 ee ee we ew we we ww tt het GROWTH AND DEVELOPMENT A. A. . .. © © © ew wo Background . . . 1. 6 2 2 6 2 © ee we we we we ew we he tee Methods ... 2. 6 © © Results . . 2... 6» «© Discussion. ....s+s IMMUNOLOGICAL, Aging Studies .. © © + CHROMOSOME, AND GENETIC STUDIES 1. 1 6 ee ee we ee ew ee we we ew tw wl ry .... th th » es Immunological Studies .... 2. 1 2 es eee eee wees Chromosome and Genetic Studies . .... 2 © «© © pe © ewe 1. Chromosome Studies . . 1... 2 2 es © se ee we we we we wwe 2. Isoleucine Misincorporation in Hemoglobin A of Marshallese 3. Detection of Mutant Proteins ....+.+«.« «ees . PARASITOLOGIC SURVEYS AND SUPPRESSIVE ANTI-HELMINTH TREATMENT oN RONGELAP AND UTIRIK, 1977-1979 . 2. 2 2 6 0 1 ee ww we ww we A. B. IX. ee ee el th Early Clinical Effects . . 2. 2. 6 2 2 2 we ee ew we ee we Dosimetric Evaluation . .. 1 2. 2 es se se tw ee we wens 1, Early Radiation . . 1. 26 © «6 6 ww we © ew we we tw ww The Accident . AGING, VII. VIII. wh lh ltl lll tll C. D. B. C. D. VI. lt lt tll Background... 1.6 6 ee ee bee ee eee he te B. IIl. «© «© A. B. Il. 2 «© C. D. Background . 2. 2 se 6 eo ee eo ew we eo we we wt ww tt et Methods ... 2. 2. 2 es ee © wo oe oe eo ww www ww Results and Discussion . .. 2... 6 + se ee ee we wwe Conclusions .. 2... 5 se ee ee we ew wwe ww ee ewe DIABETES SURVEY . . . 2 NEOPLASIA (NON-THYROID) 6 6 2 ... © 2. «© es © + @ © ee wo ew we ee hw ee eh we we he eevee veas THYROID ABNORMALITIES 2. 6 © © © 8s eo we A. B. C. A. Malignancies . 2... 2. 2 eee we eo eee eee eee eevee Benign Tumors . . 2. 6 6 6 ee ee we ee we ew we we we ww es Pituitary Tumor .. 1... 6 ee we ee we et te we he . 2. 6 © Background (Chronology of Developments) xii - © © wh ew wo we .....+.-+e«e. OMmMnNUOW WN RK DEDICATION PREFACE . = he Rs CONTENTS